Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07291908Recruiting

Inflammation Severity and miRNA-126 in Trauma

Role: lead

NCT07185529Completed

Predictors of Mortality in Multiple Trauma Patients

Role: lead

NCT06485388Not ApplicableCompleted

The Effects of Propofol and Thiopental on Nitric Oxide Production and Release in Erythrocytes

Role: lead

NCT06510751Recruiting

Evaluation of the Levels of Calcitonin Gene-related Peptide and Substance P

Role: lead

NCT06490640Completed

Factors Influencing the Mortality of Patients With Subarachnoid Haemorrhage

Role: lead

NCT05845775Completed

Evaluation Of The Effect Of Morphological Structure On Dilatational Tracheostomy Interference Location And Complications

Role: lead

NCT06043115Completed

Factors Affecting Mortality in Covid-19 Disease

Role: lead

All 7 trials loaded